Montes Archimedes Acquisition Corp. (MAAC) Shareholders Approve Roivant Sciences Deal
by Marlena Haddad on 2021-09-29 at 8:51am

Montes Archimedes Acquisition Corp. (NASDAQ:MAAC) announced that it experienced high redemptions, but secured shareholder approval of its combination with biotech firm Roivant Sciences at a special meeting yesterday.

A total of 38,400,312 shares, representing about 93.5% of all outstanding shares, were redeemed in connection with the vote leaving approximately 2,671,508 public SPAC shares and roughly $26.7 million remaining in trust. As a result, Roivant has waived its $210 million minimum cash condition. The deal is nonetheless expected to close tomorrow, September 30, and the combined company’s shares are set to trade on the Nasdaq soon thereafter under the symbol “ROIV”.

The deal included a $200 million PIPE at announcement and the public listing will still provide M&A flexibility for Roivant, which has announced a number of transactions since its deal with Montes Archimedes. Roivant expects to receive $320 million in cash and cash equivalents as a part of the merger of it subsidiary Datavant with Ciox Health and a further $100 million from SK’s investment in another subsidiary, Proteovant.

Montes Archimedes originally announced its $5 billion deal with Roivant on May 3. Basel, Switzerland-based Roivant develops an array of drug candidates acquired from peers or internally developed with its enhanced computing platform.

Only one other proposal was placed on the ballot of the special meeting. Both it and the business combination were passed by wide margins. Full vote tallies and descriptions of the measures may be found HERE.


ADVISORS

  • J.P. Morgan Securities LLC is serving as a financial advisor and capital markets advisor to Roivant and as a lead placement agent for the PIPE.
  • SVB Leerink LLC is serving as a capital markets advisor to Roivant and as a lead placement agent for the PIPE.
  • Goldman Sachs & Co. LLC is serving as a financial advisor to Roivant.
  • Cowen and Company, LLC is serving as a financial advisor and capital markets advisor to Roivant.
  • Citigroup Global Markets Inc. is serving as a placement agent for the PIPE.
  • Truist Securities, Inc. is serving as a capital markets advisor to Roivant and as a placement agent for the PIPE.
  • Davis Polk & Wardwell LLP is acting as legal counsel to Roivant.
  • Kirkland & Ellis LLP is acting as legal counsel to MAAC.
Recent Posts
by Nicholas Alan Clayton on 2025-04-24 at 6:43pm

Inflection Point Acquisition Corp. III (NASDAQ:IPCXU) announced the pricing of its $220 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “IPCXU”, Friday, April 25, 2025. The new SPAC aims to combine with a disruptive technology company in North America or Europe that is customer-focused and adaptable to...

by Nicholas Alan Clayton on 2025-04-24 at 5:11pm

Crane Harbor Acquisition Corp. (NASDAQ:CHACU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CHACU”, Friday, April 25, 2025. The Company’s primary focus will be to identify companies in the technology, real assets, and energy sectors. Crane Harbor’s management team is led...

by Nicholas Alan Clayton on 2025-04-24 at 11:59am

Flag Ship Acquisition Corporation (NASDAQ:FSHP) has entered into a definitive agreement to combine with Great Future under so far undisclosed terms. Transaction Overview Flag Ship has about $71.6 million in its current trust and has until September 20, 2025 to complete a business combination but may extend up to nine times for one month each...

by Nicholas Alan Clayton on 2025-04-24 at 8:22am

At the SPAC of Dawn SPAC momentum has not waned amid the market rally as three more SPACs are angling to price their IPOs by this evening, adding to two others and went public earlier this week. This would bring April’s tally to nine SPAC IPOs after just three in March. It has not been...

by Nicholas Alan Clayton on 2025-04-23 at 6:13pm

New Providence Acquisition Corp. III (NASDAQ:NPACU) announced the pricing of its $261 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “NPACU”, Thursday, April 24, 2025. The new SPAC aims to combine with a consumer target that has the potential to generate attractive risk-adjusted returns. New Providence III’s...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved